Community/Retail

The change in guidelines address how to assess damage to the kidneys caused by fluid loss associated with severe C. diff infection.

A recent survey showed that there is a significant preference among Americans to receive COVID-19 vaccines from a trusted health care provider, such as a pharmacist or physician.

Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, discusses how the COVID-19 pandemic has impacted the FDA’s approval process.

The potential for some people to skip the second COVID-19 vaccine dose may make more doses available to others.

The additional COVID-19 doses will provide a buffer in addition to the already procured vaccines, and will also allow experts to plan for the later part of 2021, according to a White House briefing.

New, long-term data from open-label extensions of a pair of phase 3 studies of bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets showed the sustained efficacy and safety profile of the treatment.

Research on a novel, investigational combined oral contraceptive containing drospirenone and estetrol showed that the treatment resulted in limited changes in endocrine markers.

Insulin plays a key role in regulating female reproductive function, with previous studies showing the effect of insulin deficiency on a woman’s reproductive system.

Pharmacists must first build trust with their communities in order to address vaccine hesitancy, according to Sally Arif, PharmD, BCPS.

The study authors also mention that samples taken from skin biopsies confirmed their suspicion of a delayed allergic immune response that is commonly seen in drug reactions.

Osteoporosis is a skeletal condition characterized by low bone mass and deterioration of bone tissue that leads to fragility and an increased risk of fracture.

Pharmacy Times® interviewed Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on how to approach discussing the FDA’s expedited EUA process for COVID-19 vaccines with patients with concerns about the process.

Notably, the United States has now administered the most first-shot COVID-19 vaccinations of any country, with 82.6 million.

The HIV epidemic continues while populations are less likely to reach out for testing, prevention, and treatment during the pandemic due to a variety of challenges.

A national survey found 85% of 1390 adults prefer getting prescription drugs from a local pharmacist instead of a mail order service.

The FDA has issued an emergency use authorization (EUA) for a COVID-19 diagnostic test that can confirm recent or prior COVID-19 infection.

Both diabetes types lead to severely elevated blood sugar levels that eventually cause a host of possible complications, including loss of limbs and eyesight, kidney damage, diabetic coma, and death.

Pharmacy Times® interviewed Chad Landmon, JD, chair of intellectual property and FDA practice groups at Axinn, Veltrop & Harkrider, on the FDA’s EUA process for COVID-19 vaccines.

The guidance said relaxing certain measures for vaccinated individuals may help improve COVID-19 vaccine acceptance and uptake.

Investigators have found that the evolutionary sequence of insulin has become stuck at the edge of impaired production, limiting its ability to adapt to obesity and rendering most people vulnerable to type 2 diabetes.

Pharmacy Times® interviewed Sarah Browne, MD, senior director of vaccine development at Altimmune, on the commencement of a phase 1 clinical trial of a single-dose, intranasal COVID-19 vaccine.

Third party payers have concluded that the fee-for-service system is no longer financially viable and that a new approach is necessary.

In a recent interview with Pharmacy Times, Council Powell, PharmD, region director with CVS, said pharmacists and technicians are hard at work administering COVID-19 vaccines around the country.

Recent data have shown alarmingly low rates of human papillomavirus (HPV) vaccine completion among children between 10 and 13 years of age.

Cognitive impairment includes memory and thinking problems that affect concentration, decision making and learning new things, which increases as people grow older.

The study found patients who used mHealth applications had better health outcomes and were able to regulate their health behavior more effectively than patients who did not use these apps, in addition to fewer hospital visits and lower medical costs.

The first vaccine dose alone offered strong protection against COVID-19, with efficacy that did not decline over the 3 months between doses.

Training gives pharmacy staff the tools needed to initiate uncomfortable conversations about mental health and substance use issues.